ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 670,96
1,16%
DAX
18 001,60
0,54%
Brent Oil
82,78
-1,02%
Bitcoin
61 617,42
4,22%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. NeoGenomics Inc (NEO)

  7. NeoGenomics Inc (NEO) Actualités

NEO

NeoGenomics (NEO)

NeoGenomics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:NEO
DateHeureSourceTitreSymboleSociété
30/04/202413h30Business WireNeoGenomics Reports First Quarter 2024 ResultsNASDAQ:NEONeoGenomics Inc
18/04/202413h05Business WireNeoGenomics Announces Senior Leadership PromotionsNASDAQ:NEONeoGenomics Inc
09/04/202413h00Business WireNeoGenomics to Report First Quarter 2024 Financial Results on April 30, 2024NASDAQ:NEONeoGenomics Inc
27/03/202413h30Business WireNeoGenomics Showcases Commitment to Transforming Cancer Patient Care at AACR 2024 Annual MeetingNASDAQ:NEONeoGenomics Inc
20/03/202412h00Business WireNeoGenomics Releases Inaugural Environmental, Social, and Governance (ESG) ReportNASDAQ:NEONeoGenomics Inc
06/03/202422h26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NEONeoGenomics Inc
04/03/202423h33Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:NEONeoGenomics Inc
01/03/202413h05Business WireNeoGenomics to Participate in the TD Cowen 44th Annual Health Care ConferenceNASDAQ:NEONeoGenomics Inc
26/02/202422h15Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:NEONeoGenomics Inc
20/02/202422h23Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:NEONeoGenomics Inc
20/02/202422h06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NEONeoGenomics Inc
20/02/202422h05Business WireNeoGenomics Reports Fourth Quarter and Full Year 2023 ResultsNASDAQ:NEONeoGenomics Inc
20/02/202411h37IH Market NewsMarket Cautiousness Ahead of Retail Giants’ Earnings; Oil Prices DipNASDAQ:NEONeoGenomics Inc
14/02/202416h04Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:NEONeoGenomics Inc
09/02/202421h17Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:NEONeoGenomics Inc
01/02/202413h05Business WireNeoGenomics Signs Working with Cancer Pledge in Support of EmployeesNASDAQ:NEONeoGenomics Inc
30/01/202413h05Business WireNeoGenomics to Report Fourth Quarter and Full Year 2023 Financial Results on February 20, 2024NASDAQ:NEONeoGenomics Inc
02/01/202413h05Business WireNeoGenomics to Participate in the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:NEONeoGenomics Inc
06/11/202322h29Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NEONeoGenomics Inc
08/07/202300h02Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:NEONeoGenomics Inc
03/06/202300h02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NEONeoGenomics Inc
01/06/202322h30Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:NEONeoGenomics Inc
30/05/202322h28Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NEONeoGenomics Inc
09/05/202322h40Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:NEONeoGenomics Inc
07/04/202322h07Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:NEONeoGenomics Inc
07/04/202322h04Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:NEONeoGenomics Inc
07/04/202322h02Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:NEONeoGenomics Inc
22/03/202313h00Business WireMassive Bio and NeoGenomics Announce Collaboration to Accelerate Oncology Drug Discovery and Improve Patient CareNASDAQ:NEONeoGenomics Inc
24/02/202322h43Edgar (US Regulatory)Annual Report (10-k)NASDAQ:NEONeoGenomics Inc
09/02/202321h43Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:NEONeoGenomics Inc
 Showing the most relevant articles for your search:NASDAQ:NEO

Dernières Valeurs Consultées

EU
RNO
Renault
NYSE
MCD
McDonalds
EU
MC
Lvmh Moet Hennessy Louis...
EU
CS
Axa
NYSE
NKE
Nike
SPI
SP500
S&P 500
EU
PX4
SBF 120
USI
USTECH100
US Tech 100
EU
EN
Bouygues
EU
ML
Michelin
EU
SGO
Cie de SaintGobain
NYSE
JPM
JP Morgan Chase
EU
ACA
Credit Agricole
EU
RI
Pernod Ricard
EU
BEL20
Bel 20
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés